Veronica Gonzales, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 535 Cesar Chavez Blvd, Calexico, CA 92231 Phone: 760-357-6566 |
Ana Gabriel Hernandez, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 535 Cesar Chavez Blvd, Calexico, CA 92231 Phone: 760-357-6566 |
Jesus Alejandro Nunez, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 535 Cesar Chavez Blvd, Calexico, CA 92231 Phone: 760-357-6566 |
Zaney Estrada, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 535 Cesar Chavez Blvd, Calexico, CA 92231 Phone: 760-357-6566 |
Karla Marlene Rubio-ayala, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 535 Cesar Chavez Blvd, Calexico, CA 92231 Phone: 760-357-6566 Fax: 760-357-0849 |
Frances Diaz Carvajal, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 535 Cesar Chavez Blvd, Calexico, CA 92231 Phone: 760-357-6566 Fax: 760-357-0849 |
Olivia Amaya, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 535 Cesar Chavez Blvd, Calexico, CA 92231 Phone: 760-357-6566 Fax: 760-357-0849 |
News Archive
Immune Design Corp. (IDC), a privately held biotechnology company focused on developing novel vaccines and immunotherapies for infectious disease and cancer, announced today that it has secured $32 million in Series B financing. The round was led by ProQuest Investments and was joined by current investors: The Column Group, Versant Ventures, and Alta Partners. The Series B financing brings the total amount of equity capital raised by IDC to $50 million since its inception in 2008.
Biogen Idec today announced that it has entered into a research collaboration with premier academic and research institutions to sequence the genomes of up to 1,000 patients with amyotrophic lateral sclerosis (ALS) in an effort to gain a deeper understanding about the fundamental genetic causes of ALS.
Today's headlines include reports detailing the contents of the health law's "war room" notes as well as scene-setters for today's Senate hearing testimony about healthcare.gov by Health and Human Services Secretary Kathleen Sebelius.
More than two thousand physicians, some of the top obstetric/gynecologists in the world who specialize in maternal-fetal medicine, especially high risk pregnancies, gathered today for their annual meeting in San Francisco to begin four days of intensive research presentations. Presentations each year at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting -, represent major findings in reducing high-risk pregnancies and complications.
When it comes to the prostate cancer, the disease known as the "silent killer" because it often exhibits no symptoms, to be forewarned is to be forearmed. It is the second leading cancer killer in men, just behind lung cancer. Every year, more than 218,000 men are diagnosed with prostate cancer in the United States, claiming about 28,000 lives.
› Verified 7 days ago